Nav: Home

Landmark study shows inflammation after meals varies dramatically among healthy adults

June 11, 2020

Researchers led by King's College London announced today the first published results from PREDICT, the largest ongoing nutritional study of its kind.

The results, published in Nature Medicine and presented at the American Society of Nutrition 2020, showed a wide range of metabolic responses after eating in apparently healthy adults, and that inflammation triggered by the food we eat varies up to ten-fold.

Poor metabolic responses to food, where the body takes longer and works harder to clear the blood of fat and sugar, are linked with increased risk of conditions such as low-grade inflammatory diseases including heart disease, type 2 diabetes and obesity.

The results suggest improved health could be achieved by eating foods that are personalised to reduce inflammation after meals.

Senior researcher on the study Professor Tim Spector, King's College London, said:

"When it comes to weight, we've traditionally put a huge emphasis on factors we have no control over, like genetics. The fact is, while genetics plays a role, there are many more important factors that impact an individual's response to food and maintenance of a healthy metabolism. This study shows that achieving a healthy weight requires a scientific approach to eating that takes into account an individual's unique biology."

Led by Professor Tim Spector and his team at King's College London and spin-out health science company ZOE, in collaboration with researchers across the world, the PREDICT-1 study recruited participants across the UK and the US. This consisted of 1,103 participants, including 660 identical and non-identical twins from the TwinsUK cohort.

The study measured a wide range of markers from blood glucose, fat and insulin levels to exercise, sleep and gut bacteria (microbiome) over two weeks. It is the most detailed study to date to look at all the different factors that affect our responses to food together.

Despite wide variation in metabolic responses between participants, results from identical meals eaten on different days showed that individual responses to the same foods were remarkably consistent for each person.

PREDICT-1 study results showed:
  • A wide range of factors from gut microbes, blood sugar, fat and insulin levels to exercise and sleep impact an individual's ability to achieve optimal health.

  • Genetics plays a minor role in determining personal nutritional response and even identical twins can respond very differently to the same foods.

  • Everyone is unique in the way they respond to eating food (nutritional response), so there is no one "right" way to eat.

  • The optimal time to eat for nutritional health also depends on the individual rather than fixed "perfect" mealtimes. The researchers found that some people clearly metabolised food better at breakfast while others saw no difference.

  • Optimal meal composition in terms of fat, carbohydrates, proteins and fibre (macronutrients) is also highly individual, so prescriptive diets based on fixed macronutrient ratios are too simplistic and will not work for everyone. For example, a sensitive glucose responder may need to reduce carbohydrates whereas someone else may be able to eat these freely.

  • The proportions of nutrients explain less than 25% of our responses to food, showing the importance of how we eat (time of day, sleep, exercise etc.) as well as what we eat.
Dr Sarah Berry, Senior Lecturer of Nutrition Sciences at King's College London and first author of the Nature Medicine paper and the inflammation study presented at the American Society of Nutrition 2020 conference, said:

"We found that the increase in fat and glucose in our blood after eating a meal initiates an inflammatory response which differs hugely between individuals. Dietary and lifestyle strategies to reduce prolonged elevations in blood fat and glucose may therefore be a useful target to reduce low grade inflammation, and help prevent people from developing low-grade inflammatory conditions such as type 2 diabetes and cardiovascular disease."
-end-


King's College London

Related Diabetes Articles:

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.
Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.
Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).
Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.
Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.
Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
More Diabetes News and Diabetes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at Radiolab.org/donate.     You can read The Transition Integrity Project's report here.